Revolution Medicines, Inc. RVMD
NASDAQ · United States · Health Technology
$205.26+0.78 (+0.38%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -3.06 | -2.04 | -49.8% | $0 | -100.0% | +2.2%$193.46→$197.81 |
| Q1 2026 | 2026-05-06 | -2.29 | -1.84 | -24.5% | — | — | -3.2%$147.21→$142.51 |
| Q4 2025 | 2026-02-25 | -1.86 | -1.56 | -19.2% | — | — | -2.6%$104.83→$102.15 |
| Q3 2025 | 2025-11-05 | -1.61 | -1.41 | -14.2% | — | — | +4.8%$58.57→$61.38 |
| Q2 2025 | 2025-08-06 | -1.31 | -1.12 | -17.0% | — | — | — |
| Q1 2025 | 2025-05-07 | -1.13 | -1.06 | -6.6% | — | — | — |
| Q4 2024 | 2025-02-26 | -1.12 | -0.96 | -16.7% | — | — | — |
| Q3 2024 | 2024-11-06 | -0.94 | -0.88 | -6.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.